Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients

Renal Failure

Volumn 29, Issue 2, 2007, Pages 199-205

  Lazarevic, Gordana ^a   Antic, Slobodan ^a   Vlahovic, Predrag ^b   Djordjevic, Vidosava ^b   Zvezdanovic, Lilika ^c   Stefanovic, Vladisav ^b  

^a Clinical Center

^b Faculty of Medicine

^c Clinical Center

Author keywords

Aerobic exercise; APN; Diabetes mellitus type 2; Microalbuminuria; NAGA; PC 1

Indexed keywords

ALBUMIN; CATALASE; GLUTATHIONE; GLYCOPROTEIN; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; THIOL GROUP;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYMURIA; HUMAN; INSULIN RESISTANCE; KIDNEY TUBULE DAMAGE; MALE; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PLASMA CELL; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; URINARY EXCRETION;

ACETYLGLUCOSAMINIDASE; ADULT; AEROBIOSIS; ALBUMINURIA; ANTIGENS, CD13; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYMES; EXERCISE; HUMANS; MALE; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES;

EID: 33847232875     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220601098870     Document Type: Article

References (27)

1. Viberti GC, Walker JD, Pinto J. Diabetic nephropathy. In: Alberti KGMM, DeFronzo RA, Keen H, eds. International Textbook of Diabetes Mellitus. Chichester, New York: Wiley;1992:1267-1328.
2. Verho M, Farber G, Heinen B, Grotsch H. The excretion of renal enzymes during rest and exercise: a double blind comparison between placebo and penbutolol. Int J Clin Pharmacol Res. 1987;7:27-32.
3. Houser MT. Characterization of recumbent, ambulatory, and postexercise proteinuria in the adolescent. Pediatr Res. 1987;21(5):442-446.
4. Stefanovic V, Antic S. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia, and diabetes mellitus. Clin Lab. 2004;50:271-278.
5. Stefanovic V, Antic S, Mitic-Zlatkovic M, Vlahovic P. Reversal of lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin. Diabetes Metab Res Rev. 1999;15:400-405.
6. Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Ardaillou R. Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int. 1992;41:1571-1580.
7. Dixon J, Kaklamanis L, Turley H, et al. Expression of aminopeptidase-N (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol. 1994;47:43-47.
8. Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Nivez MP, Ardaillou R. Characterization and control of expression of cell surface aminopeptidase N activity in human mesangial glomerular cells. Cell Physiol Biochem. 1992;2:57-68.
9. Lazarevic G, Antic S, Cvetkovic T, Vlahovic P, Tasic I, Stefanovic V. Physical activity programme and its effects on insulin resistance and oxidative defense in obese male patients with Type 2 diabetes mellitus. Diabetes Metab. 2006;32:583-590.
10. Pereira MA, FitzGerald SJ, Gregg EW, et al. A collection of physical activity questionnaires for health-related research. Med Sci Sports Exerc. 1997;29(Suppl):S33-S35.
11. Horak E, Hopfer SM, Sunderman W. Spectrophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem. 1981;27:1180-1185.
12. Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase I. Organ distribution and activities in body fluids. Clin Chem. 1977;23:1531-1537.
13. Mathews DR, Horsker JP, Rudeniski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
15. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601-1610.
16. Koroljuk AM, Ivanova IL, Majorova GI, Tokarev IB. Metod opredeljenja aktivnosti katalazi. Lab Delo. 1988;1:16-18.
17. Beutler E, Duron O, Kelly MB. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882-888.
18. Ellman LG. Tissue sulphydryl groups. Arch Biochem Biophys. 1959;82:70-77.
19. Andreeva IL, Kozemjakin AL, Kiskun AA. Modifikacija metoda opredelenia perekisej lipidov v teste s tiobarbiturovoj kislotoj. Lab Delo. 1988;11:41-43.
20. Jain SK, Levine NS, Duett J, Hollier B. Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism. 1990;39:971-975.
21. Valmadrid C, Klein R, Moss S, Klein B. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older onset diabetes mellitus. Arch Intern Med. 2000;160:1093-1100.
22. Fredrickson S, Ferro T, Schutrumpf A. Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction. Diabetes Care. 2004;27:1754-1755.
23. Adedapo KS, Abbiyesuku FM, Adedapo AD, Osotimehin BO. Microalbuminuria in controlled type 2 diabetes mellitus patients. Afr J Med Sci. 2001;30:323-326.
24. 2-microglobulin levels and urinary N-acetyl-β-D- glucosaminidase enzyme activities in early diagnosis of non-insulin dependent diabetes mellitus nephropathy. Diabetes Res. 1994;26:101-107.
25. Stefanovic V, Antic S, Mitic-Zlatkovic M, et al. Urinary PC-1 and N-acetyl-β-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide. Ann Clin Biochem. 2003;40:232-234.
26. 2-microglobulin andserum NAG in type 1 (insulin-dependent) diabetes mellitus without micralbuminuria. Clin Nephrol. 1987;28:227-231.
27. Shimojo N, Kitahashi S, Naka K, et al. Comparison of N-acetyl-beta-D- glucosaminidase and alanine animopeptidase activities for evaluation of microangiopathy in diabetes mellitus. Metabolism. 1987;36:277-280.